# Premarin Versus Toviaz for Treatment of Overactive Bladder

> **NCT01613170** · PHASE4 · UNKNOWN · sponsor: **The Cleveland Clinic** · enrollment: 90 (estimated)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Toviaz
- **DRUG:** Premarin
- **DRUG:** Placebo cream

## Key facts

- **NCT ID:** NCT01613170
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2018-04
- **Final completion:** 2018-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613170, "Premarin Versus Toviaz for Treatment of Overactive Bladder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01613170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*